For that reason, we endorse a generic method progress strategy which is based on The point that proteins of the exact same, or related, family (as an example, mAbs or cys-linked ADCs) present very very similar retention behavior. By being aware of this, after getting created a method for a single mAb then it is feasible to use these insights for an